The glycation site specificity of human serum transferrin is a determinant for transferrin's functional impairment under elevated glycaemic conditions.
about
Iron reduction response and demographic differences between diabetics and non-diabetics with cardiovascular disease entered into a controlled clinical trial.Increased serotransferrin and ceruloplasmin turnover in diet-controlled patients with type 2 diabetes.Computational approaches for deciphering the equilibrium and kinetic properties of iron transport proteins.
P2860
The glycation site specificity of human serum transferrin is a determinant for transferrin's functional impairment under elevated glycaemic conditions.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
The glycation site specificity ...... elevated glycaemic conditions.
@en
The glycation site specificity ...... elevated glycaemic conditions.
@nl
type
label
The glycation site specificity ...... elevated glycaemic conditions.
@en
The glycation site specificity ...... elevated glycaemic conditions.
@nl
prefLabel
The glycation site specificity ...... elevated glycaemic conditions.
@en
The glycation site specificity ...... elevated glycaemic conditions.
@nl
P50
P356
P1433
P1476
The glycation site specificity ...... elevated glycaemic conditions.
@en
P2093
Paulo R H Sousa
P356
10.1042/BJ20140133
P407
P50
P577
2014-07-01T00:00:00Z